Momentum continues to build behind the “open science movement,” propelling the debate over publication of scholarly works and the scientific process itself.
Last week, Microsoft Research announced it was adopting a policy that allows it to retain a license for research submitted to conferences or publishers in order to post it to a freely accessible online site as well. And earlier this week, pharmaceutical giant Johnson & Johnson said it will release data from clinical trials, through an agreement with the Yale University Open Data Access Project.
re/code.
